Spectrum of radiopharmaceuticals in nuclear oncology.

@article{Denoyer2006SpectrumOR,
  title={Spectrum of radiopharmaceuticals in nuclear oncology.},
  author={Delphine Denoyer and Nathalie Perek and Nathalie Le Jeune and Francis Dubois},
  journal={Current cancer drug targets},
  year={2006},
  volume={6 3},
  pages={181-96}
}
A major field of interest in nuclear medicine is in vivo tumor characterization and measurement of biological processes at cellular and molecular levels by means of positron emission tomography (PET) or single photon emission computed tomography (SPECT). Functional imaging with radiopharmaceuticals represents a useful noninvasive tool to evaluate the… CONTINUE READING